8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-22-031632
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading xfor-20221206.htm…